DOCSLIB.ORG

Innovative Herbal Tooth Paste”

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Innovative Herbal Tooth Paste” Harshavardhan et. al. Int. J. Adv. Pharm. Biotech., 2016; 2(1): 1-9 doi.org/10.38111/ijapb.20160201001 International Journal of Advances in Pharmacy and Biotechnology Vol.2, Issue-1, 2016, 1-9 Research Article Open Access I J A P B HARSHODENT – “Innovative Herbal Tooth Paste” V. Vasu Naik, Harshavardhan Pathapati*, M. Sirisha Hindu College of Pharmacy, Guntur-522002, Andhra Pradesh, India. *Corresponding author e-mail: [email protected] Received: 05 April 2016 Revised: 26 April 2016 Accepted: 02 May 2016 ABSTRACT: Herbal products have a great eminence and elegance fortifying effect in our daily healthy life. Because of this enormous engage of herbal products in our daily life, the current trend espouse towards the herbal products. Tooth paste is one of the most widely used semi-solid dosage forms available in the paste (or) gel forms which have a great effect in maintaining the health of the teeth and aesthetic effect by ascertaining the abrasive action to the teeth. Because of that herbal tooth pastes have increased demand and awareness. The harsodent is free from artificial ingredients like parabens, SLS, saccharin, NaF (Fluoride source) and chlorine sources. In the present work Clove oil, Neem oil and Syzygium cumini (Neredu) powder are the active pharmaceutical ingredients (API) which helps in maintaining the activities of the herbal tooth paste. In the present investigation three formulations were prepared F1, F2, F3 by mixing the polymers like micro crystalline cellulose MCC, methyl cellulose MC and sodium carboxy methyl cellulose SCMC and the remaining ingredients constantly in every formulation. More over the formulated tooth paste is said to be available to the consumers in cheap and cost effective manner. Key words: Herbal tooth paste, Semi-solid dosage form, Toothache (Dentalgia), Abrasive action, Active pharmaceutical ingredients (API). INTRODUCTION: loose teeth, strengthening the gums and whitening of teeth as well as promote the History of tooth paste relief from toothache. More over the first In ancient days Indians, Egyptians and organic tooth paste was invented by a Romans are using the powdered ashes, egg dentist named as Dr. Washington Wentworth shells and myrrh to cleaning their teeth. In Sheffield somewhere around early 1850’s, ancient china and Greece peoples were used similarly the Colgate Company makes a claim the crushed oysters and crab shells along that consists of they are the first tooth paste with crushed bones and horns of various inventors in the world. animals in their tooth powders, on that Definition of tooth paste: occasion they achieve the good abrasive action with their formulated tooth powders. Tooth paste is a semi-solid dosage form In early 17th and 18th century peoples made available in the paste (or) gel forms which the tooth paste for their convenience to daily have a fortifying effect in the maintaining the use. Although the first tooth powder was health of the teeth and aesthetic effect by formulated by Chinese and Romans, mainly ascertaining the abrasive action to the teeth. in their formulation containing the charcoal And also it is used to achieve the suppressive (or) bark powder, ginseng, mint and salt are actions like toothache (Dentalgia), Halitosis the common ingredients. However they and Gingivitis (a gum disease) by eliminating believe that tooth pastes are useful to fix the www.ijapbjournal.com IJAPB 1 Harshavardhan et. al. Int. J. Adv. Pharm. Biotech., 2016; 2(1): 1-9 the dental plague and food particles from the More over most of the organic tooth teeth. pastes are engaged in strengthening the teeth and gums. The modern statement towards the tooth paste is majority of the cleaning action of the Disadvantages teeth was attained by the mechanical action of the toothbrush rather than the tooth paste. SLS present in organic tooth paste However in our daily routine activities we causes the drying out of tissues present cannot be separated from tooth brushing in mouth and ultimately SLS with a toothbrush and toothpaste. Tooth responsible for mouth cancer. If more brushing activities should be done 2-3 times a day mainly carried out after every meal. amount of organic tooth paste was swallowed, it causes the harmful effects Types of Tooth pastes exist in Market like gastric irritation purgative activity Tooth pastes are mainly categorized into two and in some cases it causes liver types. damage. Fluoride source present in the organic 1. Organic tooth pastes tooth paste may be responsible for 2. Herbal tooth pastes fluorosis and also over dose leads to Organic tooth pastes matting (a tooth disease), cancer, renal Organic tooth pastes are the oral hygienic (or) kidney failure and more. products consisting of mainly the organic Triclosan is an active ingredient in some ingredients which are intended for ensuring organic tooth pastes which consists of dental hygiene and removal of dental plaque. chlorine. The chlorine converted in to Applications chloroform by reacting with tap water, here chloroform is a probable The fluoride present in the organic carcinogenic agent. And also many tooth pastes help in the preventing of more studies state that bacteriae may cavities by means of remineralization develop the tolerance against Triclosan activity which means reformation of (Triclosan present in majority of enamel and bones so that helpful in the European tooth pastes). Halitosis treatment. Most of the organic tooth pastes having It facilitates the good oral hygienic the Diethylene glycol (DEG) used as a nature and fresh breath. polymer and moisturizing agent in the Organic tooth pastes having good germ formulation may cause the toxicity to killing activity because of this which it is the consumer. Because of this reason helpful in suppression of Dentalgia and Chinese officials recall the DEG Gingivitis. containing tooth pastes products in Calcium source present in the organic 2007. tooth paste gives marked good feel of Tooth pastes containing SLS may alter free from germs and elevates the mouth the taste perception by break down of freshening phenomenon. phospholipids that enable the Organic tooth paste posses stringent bitterness to the food materials by property due to glycerin and pH inhibiting the taste buds. All the organic tooth pastes in the market containing the artificial www.ijapbjournal.com IJAPB 2 Harshavardhan et. al. Int. J. Adv. Pharm. Biotech., 2016; 2(1): 1-9 sweetener sodium saccharin gets nut powder (kunkudukai), Stevia leaves converted into bitter taste upon powder, Sodium benzoate, Titanium di oxide, addition of excess amount of saccharin Oil of winter green and Purified water. source or prolong storage of tooth paste Tooth paste Ingredients list products. Apart from API tooth paste mainly consists of Herbal tooth paste the following agents. Herbal tooth pastes are the oral hygienic Abrasives: products maintaining the health of the teeth, containing mostly plant products (or) plant Abrasives are the specialized agents useful in derivatives meant for protecting the teeth removing food particles and waste materials and gums from the germs and useful in between the teeth thereby responsible for strengthening of the teeth without causing whitening of teeth. any sort of irritations and harmful effects to Examples: CaCO3, chalk, calcium phosphate, the teeth. Basically herbal tooth pastes are colloidal silica etc. very much safe in daily usage. Humectants: Applications Humectants are the agents which gives Herbal tooth pastes are non-toxic and mechanical strength and also wetting nature non-irritant in nature. to the tooth paste. These are also called as Herbal products ensure high degree of anti clustering agents and moisturizers purity and affectivity in daily use. Examples: Glycerin, PG, PEG, sorbitol, etc. Herbal tooth pastes resorts the perfect Polymers (or) binders: germ killing and dental analgesic These agents are intended for binding aspects properties. Because of this reason it is and show the consistency of the tooth paste. helpful in suppression of Dentalgia, Examples: PEG, PG, MCC, MC, SCMC, HPMC. Gingivitis and Halitosis. More over these herbal products are Surfactants: not responsible for any sort of Surfactants are the detergents responsible for dangerous consequences upon daily foaming character in tooth paste. These are usage. also called as foaming agents. Latest researches concluded that Herbal Example: SLS, soap nut powder, etc. tooth pastes are also used in the Preservatives: treatment of pimples. However most of the herbal tooth Mainly intended for preservation purpose pastes are free from SLS, parabens, and eventually these are anti microbial in fluoride (NaF) and chlorine (Triclosan) nature. sources. And also free from artificial Example: Methyl paraben, propyl paraben, sweetener sodium saccharin. sodium benzoate etc. MATERIALS AND METHODS Sweetener: Clove oil, Neem oil, Syzygium cumini (Neredu, Gives sweetness to the tooth paste and Jamun powder), Glycerin, Propylene glycol, enhances the customer willingness towards Calcium carbonate, Chalk, Micro crystalline the product. Cellulose, Methyl cellulose, Sodium CMC, Soap Example: Na-saccharin, stevia leaves etc. www.ijapbjournal.com IJAPB 3 Harshavardhan et. al. Int. J. Adv. Pharm. Biotech., 2016; 2(1): 1-9 Flavoring agents: and the polymer for 1 minute in a stainless steel bowl. Add solution S, mix for 2 min. These are responsible for flavoring aspects in Homogenize for 3 min. Transfer into the tooth paste and give freshness to the homogenizer at 20° C. Add the Sweeteners, costumer. the API and the flavor, mix for 1 min 30sec Example: Peppermint oil, wintergreen oil, under vacuum. Add the abrasives, mix for 3 fennel, eucalyptus oil etc. min under vacuum. Add the surfactant (or) METHODOLOGY detergent, mix for 1 min 30sec under vacuum. Methods for formulation of herbal tooth The total manufacturing time, and the time T paste necessary for the dispersion of the carbonates are measured for each paste In the formulation of herbal tooth pastes the prepared. following methods are Method: 3 (Optimized method) Method: 1 Mix binder (or) polymer, humectants and also Mix the humectants and polymer for 1 minute vehicle (in an amount of 5-40% by weight of in a motor and pestle.
Load more

Recommended publications
  • An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: a Review
    Muthadi Radhika Reddy /J. Pharm. Sci. & Res. Vol. 12(7), 2020, 925-940 An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: A Review Muthadi Radhika Reddy1* 1School of pharmacy, Gurunanak Institute of Technical Campus, Hyderabad, Telangana, India and Department of Pharmacy, Gandhi Institute of Technology and Management University, Vizag, Andhra Pradesh, India INTRODUCTION 2. Useful in situations where rapid onset of action Fast dissolving drug delivery systems were first developed required such as in motion sickness, allergic attack, in the late 1970s as an alternative to conventional dosage coughing or asthma forms. These systems consist of solid dosage forms that 3. Has wide range of applications in pharmaceuticals, Rx disintegrate and dissolve quickly in the oral cavity without Prescriptions and OTC medications for treating pain, the need of water [1]. Fast dissolving drug delivery cough/cold, gastro-esophageal reflux disease,erectile systems include orally disintegrating tablets (ODTs) and dysfunction, sleep disorders, dietary supplements, etc oral thin films (OTFs). The Centre for Drug Evaluation [4] and Research (CDER) defines ODTs as,“a solid dosage 4. No water is required for the administration and hence form containing medicinal substances which disintegrates suitable during travelling rapidly, usually within a matter of seconds, when placed 5. Some drugs are absorbed from the mouth, pharynx upon the tongue” [2]. USFDA defines OTFs as, “a thin, and esophagus as the saliva passes down into the flexible, non-friable polymeric film strip containing one or stomach, enhancing bioavailability of drugs more dispersed active pharmaceutical ingredients which is 6. May offer improved bioavailability for poorly water intended to be placed on the tongue for rapid soluble drugs by offering large surface area as it disintegration or dissolution in the saliva prior to disintegrates and dissolves rapidly swallowing for delivery into the gastrointestinal tract” [3].
    [Show full text]
  • Comprehensive Review on Herbal Toothpaste
    Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 9509 - 9518 Received 05 March 2021; Accepted 01 April 2021. Comprehensive Review on Herbal Toothpaste Divya S1, Dr. J Suresh1*, Dr. S. Meenakshi 2 1. Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru-570015 2.Department of Prosthodontics, JSS Dental College, JSS Academy of Higher Education &Research, Mysuru-570015 Corresponding author Dr. J. Suresh Professor Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru-570015 Email: [email protected] Mobile No: 9480197611 ABSTRACT Herbal products for general as well as for oral health care have gained prominence around worldwide. People who aspire towards the use of herbal products often consider these products are relatively safer than products containing synthetic ingredients. Based on increased usage of herbal cosmetics we tried to make a comprehensive review on herbal toothpaste that helps to maintain a proper oral hygiene and free from periodontal disorder, reduce stain, gingivitis, calculus and caries. The present review gives basic information regarding antimicrobial potential of various herbs, formulationexcipients, that can be used in preparation of toothpaste. Key Words: Herbal toothpaste, Anti-microbial screening, Periodontal disorder, Gingivitis, calculus, Dental caries. INTRODUCTION In developing countries, the intensity of infections caused by certain pathogenic micro- organisms that may leads to mortality as well as morbidity in immune-suppressant patients [1]. Multiple abrasives, scent, green lead was used to remove the stain from teeth until mid- 19thcentury. In Medieval period rock salt, fine sand were the key ingredients used by Arabs for tooth cleaning.In the period 1950 AD, Dr.
    [Show full text]
  • Chapter 1 Controlling Drug Delivery
    chapter 1 Controlling drug delivery Overview In this chapter we will: & differentiate drug delivery systems according to their physical state & differentiate drug delivery systems according to their route of administration & differentiate drug delivery systems according to their type of drug release & discuss drug transport across epithelial barriers. Introduction KeyPoints & Continued developments in Pharmacotherapy can be defined as the treatment chemistry, molecular biology and prevention of illness and disease by means of and genomics support the drugs of chemical or biological origin. It ranks discovery and developments among the most important methods of medical of new drugs and new drug treatment, together with surgery, physical targets. & treatment, radiation and psychotherapy. There The drug delivery system are many success stories concerning the use of employed can control the pharmacological action of a drugs and vaccines in the treatment, prevention drug, influencing its and in some cases even eradication of diseases pharmacokinetic and (e.g. smallpox, which is currently the only subsequent therapeutic human infectious disease completely profile. eradicated). Although it is almost impossible to estimate the exact extent of the impact of pharmacotherapy on human health, there can be no doubt that pharmacotherapy, together with improved sanitation, better diet and better housing, has improved people’s health, life expectancy and quality of life. Tip Unprecedented developments in genomics Combinatorial chemistry is a way to and molecular biology today offer a plethora of build a variety of structurally related new drug targets. The use of modern chemical drug compounds rapidly and synthetic methods (such as combinatorial systematically. These are assembled chemistry) enables the syntheses of a large from a range of molecular entities number of new drug candidates in shorter times which are put together in different ‘ ’ than ever before.
    [Show full text]
  • WO 2010/044736 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 22 April 2010 (22.04.2010) WO 2010/044736 Al (51) International Patent Classification: (74) Agents: Bratt, Henrik et al; Jarnvagsgatan 10 A, S-251 A61K 9/24 (2006.01) A61P 25/34 (2006.01) 10 Helsingborg (SE). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/SE2009/05 1163 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (22) Date: International Filing CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, 13 October 2009 (13.10.2009) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (25) Filing Language: English HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (26) Publication Language: English ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (30) Priority Data: NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, 0802 189-1 14 October 2008 (14.10.2008) SE SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant (for all designated States except US): McNeil AB [SE/SE]; Box 941, S-25 1 09 Helsingborg (SE). (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (72) Inventors; and GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (75) Inventors/Applicants (for US only): LINDELL, Katari- ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, na [SE/SE]; Skarhult 1325, S-241 93 Eslδv (SE).
    [Show full text]
  • Dosage Form Description CODE
    Dosage Form Description CODE DOSAGE_FORM DOSAGE_FORM DESCRIPTION AERO Aerosol AEPB Aerosol Powder, Breath Activated AERB Aerosol, Breath Activated AERP Aerosol, Powder AERS Aerosol, Solution AUIJ Auto-injector AJKT Auto-injector Kit BAR Bar BEAD Beads CAPS Capsule CAPA Capsule Abuse- Deterrent CPCW Capsule Chewable CPDR Capsule Delayed Release CPEP Capsule Delayed Release Particles CSDR Capsule Delayed Release Sprinkle CDPK Capsule Delayed Release Thereapy Pack C12A Capsule ER 12 Hour Abuse-Deterrent CS12 Capsule ER 12 Hour Sprinkle C2PK Capsule ER 12 Hour Therapy Pack C24A Capsule ER 24 Hour Abuse-Deterrent CS24 Capsule ER 24 Hour Sprinkle C4PK Capsule ER 24 Hour Therapy Pack CP12 Capsule Extended Release 12 Hour CP24 Capsule Extended Release 24 Hour CPEA Capsule Extended Release Abuse-Deterrent CSER Capsule Extended Release Sprinkle CEPK Capsule Extended Release Therapy Pack CPCR Capsule Extended Release* CPSP Capsule Sprinkle CPPK Capsule Therapy Pack CART Cartridge CTKT Cartridge Kit CONC Concentrate CREA Cream CRYS Crystals DEVI Device TEST Diagnostic Test DPRH Diaphragm DISK Disk ELIX Elixir EMUL Emulsion ENEM Enema EXHA Exhaler EXHL Exhaler Liquid Dosage Form Description CODE DOSAGE_FORM DOSAGE_FORM DESCRIPTION EXHP Exhaler Powder EXHS Exhaler Solution EXHU Exhaler Suspension FILM Film FLAK Flakes EXTR Fluid Extract FOAM Foam GAS Gas GEL Gel SOLG Gel Forming Solution GRAN Granules GREF Granules Effervescent GUM Gum IMPL Implant INHA Inhaler INJ Injectable INST Insert IUD Intrauterine Device JTAJ Jet-injector (Needleless) JTKT Jet-injector
    [Show full text]
  • Formulation and Evaluation of Liposomal Drug Delivery System for Doxorubicin Hydrochloride
    FORMULATION AND EVALUATION OF LIPOSOMAL DRUG DELIVERY SYSTEM FOR DOXORUBICIN HYDROCHLORIDE A dissertation submitted to THE TAMILNADU Dr. M.G.R.MEDICAL UNIVERSITY, CHENNAI. In partial fulfillment of the requirements for the award of degree of MASTER OF PHARMACY IN PHARMACEUTICS BY REG.NO: 26091390 Under the Guidance of Prof. S.P.SENTHIL, M.Pharm., ( Ph.D.,) OCTOBER -2011 THE ERODE COLLEGE OF PHARMACY AND RESEARCH INSTITUTE ERODE -638112, TAMILNADU DEDICATED TO My Beloved Family, Teachers & Friends CERTIFICATES The Erode College Of Pharmacy and Research Institute Prof.S.P.SENTHIL, M.Pharm.,( Ph.D.,) Department of pharmaceutics, Perundurai Main Road, Veppampalayam, Erode-638112, India. e-mail : [email protected] CERTIFICATE This is to certify that the investigation in this thesis entitled “FORMULATION AND EVALUATION OF LIPOSOMAL DRUG DELIVERY SYSTEM FOR DOXORUBICIN HYDROCHLORIDE” submitted to The Tamilnadu Dr. M.G.R. Medical University Chennai. For partial fulfillment of the award of degree of Master of pharmacy in Pharmaceutics was carried out by Reg. No: 26091390 in the department of pharmaceutics, The Erode College of pharmacy, Erode, under my guidance and supervision This work is original and has not been submitted in part or full to any other degree or diploma of this or any other university. Place: Erode Prof. S.P.SENTHIL, M.Pharm.,(Ph.D.,) Date: The Erode College Of Pharmacy and Research Institute Dr.V.Ganesan, M.Pharm., Ph.D., Professor and HOD of Pharmaceutics, Perundurai Main Road, Veppampalayam, Erode-638112, India. CERTIFICATE This is to certify that the investigation in this thesis entitled “FORMULATION AND EVALUATION OF LIPOSOMAL DRUG DELIVERY SYSTEM FOR DOXORUBICIN HYDROCHLORIDE ” submitted to the Tamil Nadu Dr.
    [Show full text]
  • Medicinal Cannabis Dosage Forms in California an Overview of Cannabis Dosage Forms
    Mica Gross President Sante Botanica / COO MDBioLogics Medicinal Cannabis Dosage Forms in California An Overview of Cannabis Dosage Forms Forms of dosage are the specific vehicles by which cannabis, or cannabinoids, are delivered into the body. Cannabis (drug-containing plant) —> The “form” in which THC and other cannabinoids Extracted Oil (drug substance) —> are administered determines how they moves and Delivery / Intake (drug product) works medicinally inside the body: ie the pharmacokinetics of cannabis. Both the plant material and the oils yielded through the extraction process influence the performance of the different forms of intake, which each have a particular set of benefits. An Overview of Cannabis Dosage Forms The medicinal effect experienced by the end- user is a function of the quality of the raw material – the cannabinoid and terpene profile of the cannabis – and of the derived oil yielded during extraction. The goal is to preserve the fidelity of the volatile medicinal compounds – such as the cannabinoids, terpenes, and flavonoids – throughout the entire chain of custody so that the therapeutic effect is intact and the dose is delivered in the most efficacious means possible. An Overview of Cannabis Dosage Forms Each form of intake is formulated to take advantage of the pharmacokinetic pathways as effectively as possible in delivering a therapeutic dose of cannabinoids (e.g. THC or CBD). An Overview of Cannabis Dosage Forms Important factors when considering each form of intake: • Bioavailability – the fraction of the administered
    [Show full text]
  • Aqueous Emulsion Coating for Pharmaceutical Dosage Form
    Europaisches Patentamt 0 347 024 3> European Patent Office J) Publication number: Dffice europeen des brevets 3) EUROPEAN PATENT APPLICATION © Application number: 89303290.4 © Int. CI.4: A61K 9/32 , A61K 9/36 , A61K 9/22 © Date of filing: 04.04.89 The title of the invention has been amended © Applicant: ALZA CORPORATION (Guidelines for Examination in the EPO, A-lll, 950 Page Mill Road P.O. Box 10950 7.3). Palo Alto California 94303-0802(US) © Inventor: Wong, Patrick S.-L. © Priority: 21.04.88 US 184478 2030 Cornell Street Palo Alto California 94306(US) © Date of publication of application: Inventor: Theeuwes, Felix 20.12.89 Bulletin 89/51 1634 Fallen Leaf Lane Los Altos California 94022(US) © Designated Contracting States: AT BE CH DE ES FR GB GR IT LI LU NL SE © Representative: Evans, David Charles et al F.J. CLEVELAND & COMPANY 40-43, Chancery Lane London, WC2A UQ(GB) © Aqueous emulsion coating for pharmaceutical dosage form. © A dosage form is disclosed comprising a cured emulsion coat that surrounds a drug. The emulsion comprises a lower alkyl acrylate-lower alkyl methacrylate copolymer and ethyl cellulose. The emulsion optionally comprises a hydrophilic poly- mer. eg < CM CO CL LU Xerox Copy Centre 1 EP 0 347 024 A2 2 AQUEOUS EMULSION FOR PHARMACEUTICAL DOSAGE FORM This invention pertains to a pharmaceutical final dosage form. dosage form comprising an aqueous emulsion coat It will be appreciated by those skilled in the and to an aqueous emulsion coat. drug dispensing art that if a coating is provided that is substantially free of organic solvents when coat- 5 ing drugs, drug granules, drug powders, drug dis- BACKGROUND OF THE INVENTION pensers, and the like, such a coating would have an immediate positive value and, concomitantly, represent an advancement in the drug coating art.
    [Show full text]
  • Draft Guidance on Nicotine Active Ingredient
    Contains Nonbinding Recommendations Draft Guidance on Nicotine This draft guidance, when finalized, will represent the current thinking of the Food and Drug Administration (FDA, or the Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. To discuss an alternative approach, contact the Office of Generic Drugs. Active Ingredient: Nicotine Dosage Form; Route: Film, extended release; transdermal Recommended Studies: Three studies 1. Type of study: Bioequivalence (BE) study with pharmacokinetic (PK) endpoints Design: Single-dose, two-treatment, two-period crossover in vivo Strength: 21 mg/24 hr Subjects: Males and non-pregnant, non-lactating females, smokers Additional comments: In this document, this dosage form is referred to as a transdermal delivery system (TDS) and includes products that may be described elsewhere or known as patches or extended release films. Unless otherwise justified, the nicotine TDS should be applied to the same anatomical site on all subjects, selected from among those recommended for dosing in the approved labeling for the reference listed drug (RLD) product, and worn for 24 hours. Applicants should randomize subjects to receive either the test or RLD product in a given study period. When possible, the TDS administered in the second study period should be applied to the same anatomical site as in the first study period, but on the contralateral side of the body. Contact of the TDS with the skin is essential for the in vivo performance of the TDS, and the PK may be altered when a TDS loses its adherence to the skin.
    [Show full text]
  • Dosage Form FDA Data Element Number
    Home Drugs Development & Approval Process (Drugs) Forms & Submission Requirements Electronic Submissions to CDER Data Standards Manual (monographs) Drugs Dosage Form FDA Data Element Number. None. CDER Data Element Number. C-DRG-00201 Data Element Name. Dosage Form. Data Element OID: 2.16.840.1.113883.3.26.1.1.2 Data Element NCI Concept ID: C42636 Version Number. 008 Description. This standard provides for all drug dosage forms. The granularity of data often requires that more specific dosage form terms be stored in automated databases than are represented in publications. These dosage form terms are available not only for use in databases that track approved drug products, but also for drug products such as: those that have not been approved, investigational drug products, homeopathic drug products, biologic products, veterinary drug products, and bulk drug products. A ‘use restrictions’ column is being added to help identify where a particular dosage form set or subset should be used (a=CDER Databases, b=NDC Directory, c=Orange Book). The definitions for Lotion, Cream, Ointment, and Paste were revised on June 21, 2006 to include information that would assist the user in differentiating between these dosage forms. These changes were the result of discussions during an FDA Advisory Committee with an open public forum, scientific studies that were published in refereed pharmaceutical journals, and internal discussions by Agency personnel, including the usual adherence to the criteria that are specified in MaPP 7600.4. A 1999 Food and Drug Administration Draft Guidance for Industry states: "A dosage form is the way of identifying the drug in its physical form.
    [Show full text]
  • Thin Films As an Emerging Platform for Drug Delivery
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector asian journal of pharmaceutical sciences 11 (2016) 559–574 HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ajps Review Thin films as an emerging platform for drug delivery Sandeep Karki a,1, Hyeongmin Kim a,b,c,1, Seon-Jeong Na a, Dohyun Shin a,c, Kanghee Jo a,c, Jaehwi Lee a,b,c,* a Pharmaceutical Formulation Design Laboratory, College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea b Bio-Integration Research Center for Nutra-Pharmaceutical Epigenetics, Chung-Ang University, Seoul 06974, Republic of Korea c Center for Metareceptome Research, Chung-Ang University, Seoul 06974, Republic of Korea ARTICLE INFO ABSTRACT Article history: Pharmaceutical scientists throughout the world are trying to explore thin films as a novel Received 21 April 2016 drug delivery tool. Thin films have been identified as an alternative approach to conven- Accepted 12 May 2016 tional dosage forms. The thin films are considered to be convenient to swallow, self- Available online 6 June 2016 administrable, and fast dissolving dosage form, all of which make it as a versatile platform for drug delivery. This delivery system has been used for both systemic and local action via Keywords: several routes such as oral, buccal, sublingual, ocular, and transdermal routes. The design Thin film of efficient thin films requires a comprehensive knowledge of the pharmacological and phar- Film-forming polymer maceutical properties of drugs and polymers along with an appropriate selection of Mechanical properties manufacturing processes.
    [Show full text]
  • API & Dosage Form Development
    API and Dosage Development W I T H D A LT O N Peter Pekos [ C O M P A N Y V I S I O N ] "To make the impossible possible. Dalton Pharma Services uses its scientific and pharmaceutical expertise to bring customer ideas to life. We develop their new drug products, optimize the synthesis of therapeutic candidates, and manufacture them at the highest level of quality." [ S E R V I C E S ] Contract Research Custom Synthesis Medicinal and Flow Chemistry API Process Development Formulation Development cGMP API Manufacturing cGMP Sterile Filling Analytical and Microbiology Services FDA inspected, HC approved, & MRA with EMA API Form Development API Definition Active pharmaceutical ingredient (API) – the substance(s) in pharmaceutical drugs that is/are responsible for the beneficial health effects experienced by consumers. (1) API Selection Key factors that drive API selection (2): Crystallinity: Influences the dissolution rate and transport characteristics of the drug (3) Polymorphism: The ability of a drug substance to Solubility: take on more than one form/ The ability of a solute to dissolve in crystalline phase. Influences drug solvent. Influences desired dissolution and drug stability (i.e., concentration and drug premature degradation) (4) absorption (6) Density: Influences flow properties and Stability: compressibility (5) Influenced by moisture, excipients, temperature, pH, oxygen, light (7) Particle size distribution: Influences the ability of the drug to Density: cross blood barriers, enter cells, Influences flow properties and and absorbed by the human body compressibility (5) (2) The development stage and needs API & CTD Note: In any clinical application or new drug submission the 1) description of manufacturing (including flowcharts) is required along with 2) physiochemical characteristics (melting point, boiling point, denaturation temperature, solubility) (2.3.S.2, 2.3.S.3 and 2.3.P.3) (4) Once the API form is determined, the dosage form must be selected.
    [Show full text]